Immunophenotyping of pulmonary sarcomatoid carcinoma

BACKGROUND: Previous studies have suggested that patients with pulmonary sarcomatoid carcinoma (PSC)may benefit from immune checkpoint inhibitors (ICIs); however, relevant data are lacking. This study aimed to establish the immunophenotype of PSC by assessing PD-L1 and CD8+ T-cell infiltration. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yu, Li, Wensheng, Li, Zhenzhen, Chen, Jie, Wang, Hongtao, Jiang, Tao, Zhu, Jianfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633134/
https://www.ncbi.nlm.nih.gov/pubmed/36341325
http://dx.doi.org/10.3389/fimmu.2022.976739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633134/
https://www.ncbi.nlm.nih.gov/pubmed/36341325
http://dx.doi.org/10.3389/fimmu.2022.976739

Ejemplares similares